EP2448950
Efnasmíði á N4-(2,2-dímetýl-4-[(dívetni-fosfónoxý)metýl]-3-oxó-5-pýridó[1,4]oxasín-6-ýl)-5-flúor-N2-(3,4,5-trímetoxýfenýl)-2,4-pýri mídíndíamín dínatríumsalti
Status:
EP Einkaleyfi fallið úr gildiEP appl. date:
1.7.2010EP published:
13.1.2016EP application number:
10730679.7
EP translation filed:
30.3.2016Grant published:
15.4.2016EPO information:
European Patent Register
Max expiry date:
30.6.2030Expiry date:
30.6.2024
Title:
SYNTHESIS OF N4-(2,2-DIMETHYL-4-[(DIHYDROGEN PHOSPHONOXY)METHYL]-3-OXO-5-PYRIDO[1,4]OXAZIN-6-YL)-5-FLUORO-N2-(3,4,5-TRIMETHOXYPHENYL)-2,4-PYRIMIDINEDIAMINE DISODIUM SALT
Timeline
Today
1.7.2010EP application
13.1.2016EP Publication
30.3.2016Translation submitted
15.4.2016Registration published
30.6.2024Expires
Owner
Name:
Rigel Pharmaceuticals, Inc.Address:
1180 Veterans Boulevard, 94080, South San Francisco, CA, US
Inventor
Name:
FELFER, UlfriedAddress:
Linz, AT
Name:
GISELBRECHT, Karl-HeinzAddress:
Langholzfeld, AT
Name:
WOLBERG, MichaelAddress:
Neutraubling, DE
Agent
Name:
Árnason Faktor ehf.Address:
Guðríðarstíg 2-4, 113, Reykjavík,
Priority
Number:
270073 PDate:
2.7.2009Country:
US
Classification
Categories:
C07F 9/6561
Annual fees
Number
Paid
Expires
Payer
Number: 7
Paid: 20.6.2016
Expires: 30.6.2017
Payer: Sigurjónsson & Thor ehf.
Number: 8
Paid: 3.7.2017
Expires: 30.6.2018
Payer: Sigurjónsson & Thor ehf.
Number: 9
Paid: 2.7.2018
Expires: 30.6.2019
Payer: Sigurjónsson & Thor ehf.
Number: 10
Paid: 18.6.2019
Expires: 30.6.2020
Payer: Sigurjónsson & Thor ehf.
Number: 11
Paid: 1.7.2020
Expires: 30.6.2021
Payer: Sigurjónsson & Thor ehf.
Number: 12
Paid: 1.7.2021
Expires: 30.6.2022
Payer: Sigurjónsson & Thor ehf.
Number: 13
Paid: 20.6.2022
Expires: 30.6.2023
Payer: Patice ehf.
Number: 14
Paid: 21.6.2023
Expires: 30.6.2024
Payer: Árnason Faktor ehf.